Phase 1 safety, tolerability, pharmacokinetics and pharmacodynamic results of KCL‐286, a novel retinoic acid receptor‐β agonist for treatment of spinal cord injury, in male healthy participants

Overview of attention for article published in British Journal of Clinical Pharmacology, August 2023

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (98th percentile)
High Attention Score compared to outputs of the same age and source (98th percentile)

Mentioned by

news: 15 news outlets
blogs: 2 blogs
twitter: 11 X users

wikipedia: 1 Wikipedia page
reddit: 5 Redditors

Readers on

mendeley: 13 Mendeley

So far, Altmetric has seen 16 news stories from 15 outlets.

Could a drug developed for spinal cord injury also help treat…

Medical News Today, 16 Jul 2026

Share on PinterestA DNA repair drug initially developed to treat spinal cord injuries has treated early Alzheimer’s damage in…

Could a drug developed for spinal cord injury also help treat Alzheimer's?

AOL, 16 Jul 2026

Alzheimer’s disease is the most common cause of dementia, responsible for up to 80% of dementia cases worldwide.

A Drug Already Proven Safe in Humans Just Reduced Multiple Signs of Alzheimer's in Mice

Science Alert, 13 Jul 2026

Early in the progression of Alzheimer's and other neurodegenerative diseases, DNA inside neurons starts showing signs of…

A Human-Safe Drug Reduces Multiple Signs of Alzheimer's in Mice

Yahoo!, 13 Jul 2026

Early in the progression of Alzheimer's and other neurodegenerative diseases, DNA inside neurons starts showing signs of…

This page shows the most recent news stories that mention this research output. Click here to find out how to access more activity, including 12 additional news stories.